Concepedia

Publication | Closed Access

A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis

DOI

127

Citations

12

References

2014

Year

Timothée Lenglet, Lucette Lacomblez, Jean‐Louis Abitbol, Albert C. Ludolph, Jesús S. Mora, Wim Robberecht, Pamela J. Shaw, Rebecca M. Pruss, Valérie Cuvier, Vincent Meininger
European Journal of Neurology

Abstract

Olesoxime, although well tolerated, did not show a significant beneficial effect in ALS patients treated with riluzole.

References

YearCitations

Page 1